The World After FDA Clearance: From HOORAY! To WAIT, WHAT?

The World After FDA Clearance: From HOORAY! To WAIT, WHAT?

The World After FDA Clearance: From HOORAY! To WAIT, WHAT?Nicole Coustier
Published on: 20/08/2024

FDA clearance is a milestone—not the finish line. Why reimbursement hurdles follow right after.

Commercialization PlanningFeatured
How Hospital Financial Decisions Shape the Fate of New MedTech Innovations

How Hospital Financial Decisions Shape the Fate of New MedTech Innovations

How Hospital Financial Decisions Shape the Fate of New MedTech InnovationsNicole Coustier
Published on: 07/08/2024

Hospitals are the gatekeepers of device adoption. Learn how to align with their economics.

Commercialization PlanningFeatured
The Myth of ‘Build First, Worry Later’: Why Early Reimbursement Strategy is the Key to MedTech Survival

The Myth of ‘Build First, Worry Later’: Why Early Reimbursement Strategy is the Key to MedTech Survival

The Myth of ‘Build First, Worry Later’: Why Early Reimbursement Strategy is the Key to MedTech SurvivalNicole Coustier
Published on: 03/08/2024

Why U.S. reimbursement strategy should begin long before FDA approval if you want to survive.

Commercialization Planning